Awards and Honors
Exceptional Scholar Young Investigator Award, State University of New York (SUNY), May 2009
RESEARCH
Published Intellectual Contributions
Journal Article, Academic Journal (Published May 1, 2010)
Bulitta, J. B., Yang, J. C., Yohonn, L., Ly, N. S., Brown, S. V., D'Hondt, R. E., Jusko, W. J., Forrest, A., & Tsuji, B. T. (2010). Attenuation of Colistin Bactericidal Activity by High Incoulum of Pseudomonas Aeruginosa Characterized by a New Mechanism-Based Population Pharmacodynamic Model. Antimicrobial Agents and Chemotherapy, 54, 2051-2062.
Journal Article, Academic Journal (Published May 1, 2009)
Begic, D., & Tsuji, B. T. (2009). Daptomycin pharmacodynamics against Staphylococcus aureus hemB mutants displaying the small colony variant phenotype. Journal Antimicrobial Chemotherapy, 2009 May;63(5):977-81..
Journal Article, Academic Journal (Published April (2nd Quarter/Spring) 1, 2009)
Tsuji, B. T. (2009). Loss of vancomycin bactericidal activity against accessory gene regulator (agr) dysfunctional Staphylococcus aureus under conditions of high bacterial density.. Diagn Microbiol Infect Dis, Diagn Microbiol Infect Dis. 2009 Apr 1..
Journal Article, Academic Journal (Published January (1st Quarter/Winter) 2009)
Bulitta, J. B., Ly, N. S., Yang, J. C., Forrest, A., Jusko, W. J., & Tsuji, B. T. (2009). Development and Qualification of a Pharmacodynamic Model for the Pronounced Inoculum Effect of Ceftazidime against Pseudomonas aeruginosa. Antimicrob. Ag. Chemother., 53(1), 46-56.
Presentations Given
Conference Presentation (Academic, peer-reviewed)
Tsuji, Brian, Annual Meeting of the Infectious Diseases Society of America & 49th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, USA; September 12 - 15, 2009., "
1.Yohonn L, Brown SV, Bulitta JB, Forrest A, Sun H, McPhee C, Holden PN, Kelchlin PA, Dodds Ashley E, Haas CE, Hardy D, Tsuji BT. Bactericidal Activity of Colistin against Clinical Isolates of Pseudomonas aeruginosa at High and Low Bacterial Density. Poster A-119. 109th General Meeting of the American Society for Microbiology, Philadelphia, USA; May 17 – 21, 2009.
2.Bulitta JB, Okusanya OO, Forrest A, Bhavnani SM, Reynolds DK, Pai MP, Still GJ, Fernandes P, Ambrose PG. Population Pharmacokinetics (PPK) of CEM-102 in Healthy Subjects. 49th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, USA; September 12 - 15, 2009.
3.Bulitta JB, Li J, Poudyal A, Yu HH, Owen RJ, Tsuji BT, Nation RL, Forrest A. Quantifying Synergy of Colistin (C) Combinations against MDR Gram Negatives by Mechanism-based Models (MBM). 49th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, USA; September 12 - 15, 2009.
4.Tsuji BT, Bulitta JB, Kelchlin PA, Holden PN, Forrest A. Determining the “Active Fraction” of Daptomycin against MRSA by Evaluating Bactericidal Activity in the Presence of Protein and Pharmacodynamic (PD) Modeling. 49th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, USA; September 12 - 15, 2009.
5.Tsuji BT, Bulitta JB, Forrest A, Holden PN, Kelchlin PA, Brown T, Kuhn M, Irvine B, Skerlos L, Hanna D. Linezolid (LZD) Pharmacodynamics and Pharmacogenomics (PD/PG) against Sensitive and Resistant Subpopulations of Enterococci faecalis (EF) Characterized by a New Mechanism-Based Model. 49th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, USA; September 12 - 15, 2009.
6.Tsuji BT, Bulitta JB, Forrest A, Kelchlin PA, Brown T, Holden PN, Pai MP, Bhavnani SM, Fernandes P, Jones RN, Ambrose PG. Pharmacokinetics-Pharmacodynamics (PK-PD) of CEM-102 Against Methicillin-Resistant Staphylococcus aureus (MRSA) Using an In Vitro PD Model (IVPM) and Mechanism-Based (MB) Modeling. 49th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, USA; September 12 - 15, 2009.
7.Bergen PJ, Bulitta JB, Tsuji BT, Forrest A, Nation RL, Li J. In Vitro Pharmacodynamics (PD) of the Combination of Colistin (C) & Imipenem (I) against MDR Pseudomonas aeruginosa (Pa) at Multiple Inocula. Modeling. 49th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, USA; September 12 - 15, 2009.
8.Li J, Poudyal A, Yu HH, Owen RJ, Bulitta JB, Forrest A, Tsuji BT, Nation RL. PD of Rational Colistin (C) Combinations against MDR Klebsiella pneumoniae (Kp), Pseudomonas aeruginosa (Pa) and Acinetobacter baumannii (Ab). 49th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, USA; September 12 - 15, 2009. 9.Okusanya OO, Bulitta JB, Forrest A, Tsuji BT, Bhavnani SM, Still JG, Fernandes P, Ambrose PG. CEM-102 Dosage Regimen Decision Support Using Population Pharmacokinetic (PPK) and Mechanism-Based Pharmacokinetic-Pharmacodynamic (PK-PD) Models. 47th Annual Meeting of the Infectious Diseases Society of America, Philadelphia, PA, USA; October 29 - November 1, 2009.
10.Bulitta JB, Bergen PJ, Tsuji BT, Li J, Nation RL, Forrest A. Population Pharmacodynamic Modeling of the Mechanism of Action and Emergence of Sub-populations of Pseudomonas aeruginosa for a Wide Range of Colistin Dosage Regimens. American Conference on Pharmacometrics, Mashantucket, CT, USA; October 4-7, 2009.
11.Bulitta JB, Ly NS, Forrest A, D’Hondt RE, Tsuji BT. Mechanism-based Modeling of Beta-lactam Antibiotics Binding to Specific Penicillin-Binding Proteins of Pseudomonas aeruginosa at Several Initial Inocula. American Conference on Pharmacometrics, Mashantucket, CT, USA; October 4-7, 2009.
12.Bulitta JB, Forrest A, Poudyal A, Yu HH, Owen RJ, Li J, Tsuji BT, Nation RL. Rational design of colistin and ciprofloxacin combination regimens against Pseudomonas aeruginosa using mechanism-based models (Abstr. 3192). 20th European Congress of Clinical Microbiology and Infectious Diseases, Vienna, April 10 - 13, 2010.
13.Li J, Poudyal A, Yu H, Owen R, Bulitta J, Forrest A, Tsuji B, Nation R. Targeting multidrug-resistant Pseudomonas aeruginosa: pharmacodynamics of the combination of colistin and ciprofloxacin (Abstr. 2063). 20th European Congress of Clinical Microbiology and Infectious Diseases, Vienna, April 10 - 13, 2010.
14.Bulitta JB, Li J, Poudyal A, Yu HH, Owen RJ, Tsuji BT, Nation RL, Forrest A. Mechanism-based Modelling of the Synergy of Colistin Combinations against Multidrug-Resistant Gram Negative Bacteria. PAGE 19 (2010) Abstr 1918 [www.page-meeting.org/?abstract=1918], Berlin, Germany, June 8 - 11, 2010.", TOTAL OF 14 Abstract publications. (Published in Proceedings: Yes; ).
|
